Ready. Set. CRISPR.

Ready. Set. CRISPR.

CRISPR/CAS9 TECHNOLOGY BUILDS UP STEAM The world definitely weighed in after Chinese scientists published a paper detailing the use of CRISPR/Cas9 to edit nonviable human embryo genomes. While the embryos used were never intended to become a living human being, this...
Curing Hepatitis C

Curing Hepatitis C

The biotech industry gets its fair share of criticism. Take for example HBO’s John Oliver shining his light on biopharma last week and proclaiming drug companies are like high school boyfriends: more interested in getting into patients’ bodies than...
Longevity In Biotech

Longevity In Biotech

Longevity has fascinated mankind for centuries, from ancient myths about fountains of youth to current speculation around caloric restriction. With our increased scientific understanding of aging, clinical validation and commercialization of treatments are near. The...

The Bispecific Antibody: A Lethal Hybrid

Amgen’s acute lymphoblastic leukemia treatment, Blincyto, coasted past the FDA bottleneck ahead of schedule, gaining approval earlier this month as a “first of its kind” immunotherapy. The FDA designated Blincyto as a breakthrough therapy and an orphan product on top...
Capturing Circulating Tumor Cells

Capturing Circulating Tumor Cells

After using diagnostic technology to establish the existence of cancer, determining the severity is the next step toward developing a game plan. If metastasis is in the picture, strengthening your defensive line-up is a must. The dissemination of circulating tumor...